N-((S)-1-((S)-2-amino-1-cyclohexyl-2-oxoethylamino)-3-cyclohexyl-1-oxopropan-2-yl)isoxazole-5-carboxamide

ID: ALA4095478

Chembl Id: CHEMBL4095478

PubChem CID: 137654325

Max Phase: Preclinical

Molecular Formula: C21H32N4O4

Molecular Weight: 404.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)[C@@H](NC(=O)[C@H](CC1CCCCC1)NC(=O)c1ccno1)C1CCCCC1

Standard InChI:  InChI=1S/C21H32N4O4/c22-19(26)18(15-9-5-2-6-10-15)25-20(27)16(13-14-7-3-1-4-8-14)24-21(28)17-11-12-23-29-17/h11-12,14-16,18H,1-10,13H2,(H2,22,26)(H,24,28)(H,25,27)/t16-,18-/m0/s1

Standard InChI Key:  CAYJNBJPGBBDAS-WMZOPIPTSA-N

Alternative Forms

  1. Parent:

    ALA4095478

    ---

Associated Targets(Human)

F2RL1 Tchem Proteinase-activated receptor 2 (703 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 404.51Molecular Weight (Monoisotopic): 404.2424AlogP: 2.29#Rotatable Bonds: 8
Polar Surface Area: 127.32Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.43CX Basic pKa: CX LogP: 1.92CX LogD: 1.92
Aromatic Rings: 1Heavy Atoms: 29QED Weighted: 0.61Np Likeness Score: -0.61

References

1. Yau MK, Suen JY, Xu W, Lim J, Liu L, Adams MN, He Y, Hooper JD, Reid RC, Fairlie DP..  (2016)  Potent Small Agonists of Protease Activated Receptor 2.,  (1): [PMID:26819675] [10.1021/acsmedchemlett.5b00429]
2. Klösel I, Schmidt MF, Kaindl J, Hübner H, Weikert D, Gmeiner P..  (2020)  Discovery of Novel Nonpeptidic PAR2 Ligands.,  11  (6): [PMID:32551018] [10.1021/acsmedchemlett.0c00154]
3. Majewski, Mark W., Gandhi, Disha M., Holyst, Trudy, Wang, Zhengli, Hernandez, Irene, Rosas, Ricardo, Zhu, Jieqing, Weiler, Hartmut, Dockendorff, Chris.  (2020)  Synthesis and initial pharmacology of dual-targeting ligands for putative complexes of integrin alphaVbeta3 and PAR2,  11  (8): [PMID:33479689] [10.1039/d0md00098a]

Source